I-Mab Biopharma (IMAB) to Divest Assets and Business Operations in China streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
By Rob Curran Biotech concern I-Mab agreed to sell its Chinese unit to affiliate I-Mab Biopharma (Hangzhou)for up to $80 million after contingencies, and it.
People | Columbia Journalism School columbia.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from columbia.edu Daily Mail and Mail on Sunday newspapers.
Adjunct Faculty | Columbia Journalism School columbia.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from columbia.edu Daily Mail and Mail on Sunday newspapers.